Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Ewing sarcoma: Prognostic criteria, outcomes and future treatment

  • University of Texas Southwestern Medical Center
  • Vanderbilt University

Producción científica › revisión exhaustiva

63 Citas (Scopus)

Resumen

Ewing sarcoma (EWS) is a bone tumor occurring primarily in adolescence and young adulthood. Multi-institutional clinical trials have improved the outcome for patients with nonmetastatic EWS, but not with metastatic EWS. Furthermore, although 30% of EWS recur, multi-institutional studies have not been completed for this high-risk group. Planning such studies has been hampered by both the lack of novel therapies and the inability to incorporate the biology of EWS. While the importance and detail of the EWS-FLI-1 translocation between chromosomes 11 and 22 are described, these have not yet led to new drug development for this orphan tumor. However, recent evidence supporting novel cytotoxic therapy, antiangiogenic therapy, and receptor-targeted therapy provides reason for optimism for patients with high-risk disease.

Idioma originalEnglish
Páginas (desde-hasta)617-624
Número de páginas8
PublicaciónExpert Review of Anticancer Therapy
Volumen8
N.º4
DOI
EstadoPublished - abr 2008
Publicado de forma externaSí

Huella

Profundice en los temas de investigación de 'Ewing sarcoma: Prognostic criteria, outcomes and future treatment'. En conjunto forman una huella única.

Citar esto